Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Otsuka Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Otsuka Holdings wird ein jährliches Gewinn- und Umsatzwachstum von 5.9% bzw. 0.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 7.9% betragen.

Wichtige Informationen

6.9%

Wachstumsrate der Gewinne

6.8%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	13.3%
Wachstumsrate der Einnahmen	0.3%
Zukünftige Eigenkapitalrendite	7.9%
Analystenabdeckung	Good
Zuletzt aktualisiert	29 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Otsuka Holdings Co., Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 02

Recent updates

Otsuka Holdings Co., Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 02

Is There An Opportunity With Otsuka Holdings Co., Ltd.'s (TSE:4578) 24% Undervaluation?

Apr 20

Is Otsuka Holdings (TSE:4578) A Risky Investment?

Mar 15

Gewinn- und Umsatzwachstumsprognosen

TSE:4578 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (JPY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	2,166,448	209,390	206,450	N/A	10
12/31/2025	2,183,447	239,611	255,003	N/A	11
12/31/2024	2,206,430	226,339	234,128	N/A	11
3/31/2024	2,089,741	137,563	N/A	N/A	N/A
12/31/2023	2,018,568	121,616	N/A	N/A	N/A
9/30/2023	1,950,959	184,702	135,359	226,774	N/A
6/30/2023	1,871,228	166,860	122,224	206,555	N/A
3/31/2023	1,806,034	172,194	111,337	226,032	N/A
12/31/2022	1,737,998	133,906	N/A	N/A	N/A
9/30/2022	1,656,978	109,845	53,563	202,725	N/A
6/30/2022	1,593,768	103,809	72,220	219,752	N/A
3/31/2022	1,541,795	104,036	101,635	213,365	N/A
12/31/2021	1,498,276	125,463	115,712	228,864	N/A
9/30/2021	1,463,284	147,019	N/A	N/A	N/A
6/30/2021	1,446,198	152,734	N/A	N/A	N/A
3/31/2021	1,420,055	155,109	N/A	N/A	N/A
12/31/2020	1,422,826	148,137	N/A	N/A	N/A
9/30/2020	1,434,441	143,398	103,870	198,659	N/A
6/30/2020	1,420,552	146,198	131,591	216,159	N/A
3/31/2020	1,421,844	145,709	141,592	220,990	N/A
12/31/2019	1,396,240	127,151	N/A	N/A	N/A
9/30/2019	1,372,665	116,333	149,898	222,128	N/A
6/30/2019	1,344,787	86,379	112,554	183,817	N/A
3/31/2019	1,311,287	78,918	77,033	150,389	N/A
12/31/2018	1,291,981	82,492	62,213	135,821	N/A
9/30/2018	1,269,004	117,106	54,841	122,032	N/A
6/30/2018	1,262,916	133,942	26,641	93,786	N/A
3/31/2018	1,254,410	114,206	29,495	106,043	N/A
12/31/2017	1,239,952	112,492	N/A	102,832	N/A
9/30/2017	1,211,772	75,029	N/A	N/A	N/A
6/30/2017	1,196,154	88,267	N/A	104,452	N/A
3/31/2017	1,193,159	94,933	N/A	N/A	N/A
12/31/2016	1,195,547	92,563	N/A	142,004	N/A
9/30/2016	1,240,874	71,521	N/A	N/A	N/A
6/30/2016	1,294,177	61,301	N/A	119,802	N/A
3/31/2016	1,342,728	68,735	N/A	N/A	N/A
12/31/2015	1,445,227	84,053	N/A	253,873	N/A
12/31/2014	1,599,424	151,237	N/A	118,047	N/A
9/30/2014	1,541,631	163,443	N/A	178,279	N/A
6/30/2014	1,515,577	156,499	N/A	N/A	N/A
3/31/2014	1,452,759	150,956	N/A	226,461	N/A
12/31/2013	1,403,125	174,046	N/A	N/A	N/A
9/30/2013	1,318,459	146,774	N/A	177,947	N/A
6/30/2013	1,253,580	130,185	N/A	N/A	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 4578Das prognostizierte Gewinnwachstum (5.9% pro Jahr) liegt über der Sparquote (0.2%).

Ertrag vs. Markt: 4578Die Erträge des Unternehmens (5.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt JP (8.4% pro Jahr).

Hohe Wachstumserträge: 4578Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 4578Die Einnahmen des Unternehmens (0.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt JP (3.9% pro Jahr).

Hohe Wachstumseinnahmen: 4578Die Einnahmen des Unternehmens (0.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 4578Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (7.9 %).

Otsuka Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Otsuka Holdings Co., Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ended December 31, 2023

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the First Half of Fiscal Year 2023

Otsuka Holdings Co., Ltd. Revises Consolidated earnings Guidance for the Fiscal Year Ending December 31, 2022

Otsuka Holdings Co., Ltd. Revises Consolidated Earrings Guidance for the Fiscal Year Ending December 31, 2022

Recent updates

Now 21% undervalued

Otsuka Holdings Co., Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

New minor risk - Profit margin trend

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Is There An Opportunity With Otsuka Holdings Co., Ltd.'s (TSE:4578) 24% Undervaluation?

Final dividend of JP¥60.00 announced

Is Otsuka Holdings (TSE:4578) A Risky Investment?

Otsuka Holdings Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Otsuka Holdings Co., Ltd. Announces Year-End Dividend for the Year Ended December 31, 2023, Payable on March 29 , 2024; Provides Second Quarter-End Dividend Guidance for the Fiscal Year 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Otsuka Holdings Co., Ltd. Revises Dividend for the Full Year Ending December 31, 2023, Payable on March 29 , 2024

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ended December 31, 2023

Upcoming dividend of JP¥50.00 per share at 1.9% yield

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Otsuka Holdings Co., Ltd. to Report Fiscal Year 2023 Results on Feb 14, 2024

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

Now 21% undervalued

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Otsuka Holdings Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the First Half of Fiscal Year 2023

Otsuka Pharmaceutical Co., Ltd. Announces Positive Results of Phase III Trial in Japan Showing Reduced Agitation in Patients with Alzheimer's Dia Treated with Brexpiprazole

Upcoming dividend of JP¥50.00 per share at 1.8% yield

Otsuka Holdings Co., Ltd. to Report Q2, 2023 Results on Jul 31, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued

Otsuka Holdings Co., Ltd., Annual General Meeting, Mar 30, 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Otsuka Holdings Co., Ltd. Provides Dividend Guidance for Fiscal Year Ending 2023

Otsuka Pharmaceutical Co., Ltd. (Otsuka) Files an Application in Japan for an Additional Indication for Rexulti

Now 23% undervalued after recent price drop

Otsuka Holdings Co., Ltd. to Report Fiscal Year 2022 Results on Feb 14, 2023

Upcoming dividend of JP¥50.00 per share

Now 21% undervalued

Otsuka Medical Devices Co., Ltd. and Recor Medical, Inc. Announce Submission of Application for Pre-Market Approval of the Paradise uRDN to the U.S. FDA

Otsuka Holdings Co., Ltd. Revises Consolidated earnings Guidance for the Fiscal Year Ending December 31, 2022

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Otsuka Holdings Co., Ltd. Revises Consolidated Earrings Guidance for the Fiscal Year Ending December 31, 2022

Otsuka Holdings Co., Ltd. to Report Q2, 2023 Results on Oct 31, 2022

U.S. FDA Acceptance of New Drug Application for Aripiprazole 2-Month by Otsuka America Pharmaceutical, Inc

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the First Half Ended June 30, 2022

Price target increased to JP¥4,725

Otsuka Holdings Co., Ltd. to Report Q2, 2022 Results on Jul 29, 2022

Upcoming dividend of JP¥50.00 per share

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Second Quarter of Fiscal Year Ending December 31, 2022; Provides Earnings Guidance for the Year Ending December 31, 2022

Otsuka Holdings Co., Ltd. to Report Q1, 2022 Results on May 13, 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Second Quarter and Full Year of Fiscal Ending December 31, 2022

Otsuka Holdings Co., Ltd. Revises Earnings Guidance for the Fiscal Year 2021

Upcoming dividend of JP¥50.00 per share

Third quarter 2021 earnings released: EPS JP¥64.97 (vs JP¥75.52 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥86.15 (vs JP¥90.54 in 2Q 2020)

Upcoming dividend of JP¥50.00 per share

First quarter 2021 earnings released: EPS JP¥82.39 (vs JP¥69.54 in 1Q 2020)

Full year 2020 earnings released: EPS JP¥273 (vs JP¥235 in FY 2019)

Revenue and earnings miss expectations

New 90-day low: JP¥4,224

Full year 2020 earnings released: EPS JP¥273 (vs JP¥235 in FY 2019)

Revenue and earnings miss expectations

Otsuka Holdings Co., Ltd., Annual General Meeting, Mar 30, 2021

New 90-day high: JP¥4,544

Otsuka Holdings Co., Ltd. to Report Fiscal Year 2020 Results on Feb 12, 2021

Otsuka Holdings Co., Ltd. to Report Q3, 2020 Results on Nov 13, 2020

Otsuka Holdings Co., Ltd. to Report Q2, 2020 Results on Aug 07, 2020

Gewinn- und Umsatzwachstumsprognosen